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Abstract
Background—Recently, the National Institutes of Health Roadmap for Medical Research
initiative led a large-scale effort to develop the Patient-Reported Outcomes Measurement
Information System (PROMIS). PROMIS’s main goal was to develop a set of item banks and
computerized adaptive tests for the clinical research community. Asthma, as the most common
chronic childhood disease, was chosen for a disease-specific pediatric item bank.
Objectives—The primary objective of this research is to present the details of the psychometric
analyses of the asthma domain items.
Methods—Item response theory (IRT) analyses were conducted on a 34–asthma item bank. Test
forms containing PROMIS Pediatric Asthma domain items were completed by 622 children ages 8
to 12. Items were subsequently evaluated for local dependence, scale dimensionality, and
differential item functioning.
Results—A 17-item pool and an 8-item short form for the new PROMIS Pediatric Asthma
Impact Scale (PAIS) were generated using IRT. The recommended 8-item short form contains the
item set that provides the maximum test information at the mean (50) on the T-score metric. If
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more score precision is required, the complete 17-item pool is recommended and may be used in
toto or as the basis of a computerized adaptive test (CAT). A shorter test form can also be created
and scored on the same scale.
Conclusions—The present study presents the PROMIS Pediatric Asthma Impact Scale (PAIS)
developed with IRT, and provides the initial calibration data for the items.
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Introduction
Asthma is the most common chronic childhood disease and it imposes a significant negative
impact on the health, quality of life, and finances of those affected. In 2007, over 9.5 million
children (13%) had ever been diagnosed with asthma, and almost 6.2 million (9%) currently
have asthma (1). Using recent estimates of pediatric asthma medical expenditures ($1004.60
per child) in 2007 U.S. dollars (2), the annual direct medical cost for pediatric asthma is
approximately $6.2 billion dollars. Including adults with asthma increases the cost estimate
to $37.2 billion in 2008 U.S. dollars, representing a substantial proportion of healthcare
costs in the United States.
With the large burden of asthmatic disease in the population comes the need to evaluate the
effectiveness and potential adverse effects of pharmacologic agents, therapies, interventions,
and disease management strategies. Functions of assessment and monitoring are closely
linked to the concepts of severity, control, and responsiveness to treatment (3). Notably, in
the 2009 National Heart, Lung and Blood Institute (NHLBI) Strategic Plan for Pediatric
Respiratory Disease Research Report, one of the seven priority areas for research was
“improved assessment, diagnosis, and treatment of pediatric respiratory diseases” (4). Better
treatment and management lead to an improved quality of life for children and adults with
asthma (5).
New asthma treatments and interventions are evaluated using asthma quality of life scales
and questionnaires. Over the past several decades, researchers began a formal development
of asthma-specific quality of life scales and questionnaires such as those by Juniper et al.
(6), Creer et al. (7), and Hyland et al. (8). In subsequent years, the number of asthma
symptoms and quality of life scales expanded considerably. These included the Pediatric
Quality of Life Inventory Generic Core Scales and Asthma Module (PedsQL) (9, 10), the
Pediatric Asthma Diary (11–13), DISABKIDS Asthma Module (14, 15), Marks Asthma
Quality of Life Questionnaire (16), Merck’s Asthma Therapy Assessment Questionnaire
(17), and the Integrated Therapeutics Group Child Asthma Short Form (18). The most recent
asthma questionnaires to be developed focus specifically on asthma control: the Childhood
Asthma Control Test (19) and Test for Respiratory and Asthma Control in Kids (TRACK)
(20).
All of the aforementioned asthma-specific quality of life scales were developed using
classical test theory. In classical test theory, the item and scale statistics apply only to the
specific group of subjects who took the test (21). Thus, the scales need to be validated across
a range of different populations before they can be generalizable.
Asthma scales/questionnaires that have been developed with classical test theory often have
gaps in their ability to measure the full spectrum of disease (22, 23). In contrast, with item
response theory (IRT)-calibrated items, one can construct a measure that is useful across the
full continuum of disease. Adams et al. (22) and Ahmed et al. (23) were some of the first
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researchers to apply IRT to evaluating asthma-specific quality of life questions. Both
identified gaps in existing scales/measurements. Adams et al. found that the Marks Asthma
Quality of Life Questionnaire (AQLQ) showed smaller differences in scores at both the
lower and upper ends of the scale than in the middle, whereas Ahmed et al. observed
substantial ceiling effects in the 30 Second Asthma Test. Thus these asthma scales do not
span the entire continuum of disease and make it difficult to evaluate the effects of new
treatments and interventions in children with the most severe disease.
The Patient-Reported Outcomes Measurement Information System (PROMIS), part of the
National Institutes of Health Roadmap Initiative, was designed to develop better measures of
patient-reported outcomes such as pain, fatigue, and physical functioning. PROMIS includes
the development of domain item banks, and computerized adaptive tests based on IRT for
the clinical research community (23). The PROMIS Pediatric project focused on the
development of self-report PRO item banks across several health domains for youth ages 8
to 17 years. The primary focus was on the measurement of generic health domains that are
important across a variety of illnesses (24). Asthma was chosen for a disease-specific item
bank to measure symptoms of and impact of disease by patient self-report.
We aimed to identify a set of items that spanned the entire asthma severity/control
continuum and that are valid in a wide range of subpopulations. The goals of the present
paper are to describe the details of the IRT analyses of the asthma domain items. Lastly we
present the 17-item pool and the 8-item short form that resulted from the IRT analyses.
Methods
As other PROMIS-related scales were designed to measure pain, fatigue, emotional,
physical and social functions, the asthma item bank focused on asthma-specific symptoms
and impacts, as described in the NHLBI Asthma Guidelines ERP-3 (3). For the development
of the asthma impact items, we adopted the following asthma domain definition: “Asthma
causes several symptoms for children that are not addressed in the generic item banks which
include cough, wheeze, shortness of breath, and avoidance of triggers. Asthma is also
associated with impacts such as missing school or activities with other children. The
PROMIS pediatric asthma item bank focuses on symptoms specific to asthma” (Irwin et al.,
submitted).
The PROMIS Pediatric Asthma item banks were created using a strategic item generation
methodology developed by the PROMIS Network (Irwin et al., submitted) (25). Six phases
of item development were implemented: identification of existing items, item classification
and selection, item review and revision, focus group input on domain coverage, cognitive
interviews with individual items, and final revision before field testing. Identification of
items refers to the systematic search for existing items in currently available pediatric scales.
The systematic search was utilized to identify an initial item pool of 169 asthma items.
These asthma items included asthma items collected from the following scales: Pediatric
Quality of Life, Generic and Asthma Module v 3.0 (PedsQL) (9–10), the Pediatric Asthma
Diary (11–13), the DISABKIDS Asthma Module (14, 15), with permission from the authors.
Additional items were written by the authors to fill in previously uncovered content areas
identified by patient, parents, or the research team. Focus groups input and cognitive
interview results were published previously (26, 27). Items successfully screened through
the process were sent to field testing. The final PROMIS pediatric asthma item set contained
34 asthma items (26).
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Participants were recruited in hospital-based outpatient general pediatrics and subspecialty
clinics and in public school settings between January 2007 and May 2008 in North Carolina
and Texas. Parental informed consent and minor assent were obtained for all children taking
the survey.
The 34 PROMIS asthma items were administered along with the items from the PedsQL
Asthma Module and the DISABKIDS asthma module (26). Children (N = 622) completed
one of the two testing forms (Asthma Form 1, Asthma Form 2). The details of the sampling
plan are described elsewhere (Irwin et al., submitted). Most (32 of 34) asthma items had a 7-
day recall period and used standardized 5-point response options (never, almost never,
sometimes, often, almost always). For 2 items, participants responded to items on a response
scale in reference to the number of days (0 through 7 days).
Statistical and Psychometric Methods
As outlined in Reeve et al. (28), psychometric evaluation was completed sequentially using
the steps outlined below. First, to verify coding and see that there were no empty response
categories for any item, descriptive statistics were computed as a preliminary check on the
validity of the data. Included in these checks were tables of marginal frequencies of item
responses and the correlations of item scores with the total summed score.
Second, confirmatory factor analysis (CFA) of the interitem polychoric correlation matrix
was conducted to verify, prior to IRT calibration, that the latent variable, asthma impact,
was unidimensional. However, because the items were primarily selected from existing
scales, there was a potential for content-specific factors. In other words, because there could
be considerable overlap in item content, responses to subsets of the items may be more
related than expected based on the relationship with the general factor, asthma impact. Thus,
in addition to a single-factor model, fitting additional factors, and/or residual correlations,
served as an indication of local dependence (LD) for pairs or small numbers of items,
violating the local independence assumption of unidimensional IRT (29). Items were set
aside from subsets that exhibited LD. These analyses were performed using the mean and
variance adjusted weighted least squares algorithm (WLSMV) as implemented in the
computer program Mplus (30).
Third, based on the CFA findings, locally independent items were calibrated using
Samejima’s graded response model (GRM; 1, 31, 32) in the software Multilog (33). The
GRM estimates a slope or discrimination parameter (a), reflecting the degree of association
of the item responses with the latent construct being measured, and four threshold
parameters (bk) (for five response option items) that indicate the level of asthma impacts at
which a response in a given category or higher becomes probable. The fit of the IRT model
to the data was examined using the S-X2 statistic (34); and generalized by Bjorner et al. (35).
As a goodness of fit statistic, a nonsignificant S-X2 value suggests adequate fit of the model
to the data.
Fourth, differential item functioning (DIF) was investigated between males and females
using the IRT-LR (Likelihood Ratio) DIF detection procedure (36) as implemented in the
software IRTLRDIF (37). In this case, the presence of DIF indicates that the relation of item
responses with the latent variable differs between boys and girls. Such a difference suggests
that some other factor, related to gender but different from the construct being measured,
influences item responses, which is a violation of the assumption of unidimensionality. Here
again, a nonsignificant χ2 indicates a lack of DIF. DIF detection requires many tests of
significance, so the Benjamini-Hochberg procedure (38, 39) was used to control for multiple
comparisons.
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Finally, though IRT scale scores may be computed from either item response patterns or
summed scores, we expect scale scores for summed scores to be used more often. The
Appendix provides a score translation table to be used for this purpose (40). The IRT scale
scores reported here use the North Carolina sample as the reference group.
Results
Test forms containing PROMIS pediatrics asthma items were completed by a total of 622
respondents. Table 1 describes participant characteristics by asthma form (Irwin et al.,
submitted); note the analyses conducted with Forms 1 and 2 are conducted in exactly the
same manner. The sample participants completing the asthma forms were about 44% female
and 63% of children were between the ages 8 to 12 years old. Forty-six percent were
Caucasian, 35% Black, 7% multiracial, and 12% other races (Asian/Pacific Islanders, Native
Americans, and Other Races). Fourteen percent of the sample was of Hispanic ethnicity. The
vast majority of the adults providing informed consent for the children were parents (92%)
or grandparents (4%) of the child. The educational attainment of these parents or guardians
ranged from less than high school (8%) to advanced degree (9%), with 22% reporting a
college degree, 37% some college, and 24% a high school diploma. Approximately 28% of
the children participating in the survey had a chronic illness diagnosis during the past 6
months. The children participating in the survey had a range of asthma severity and asthma
control, with approximately half reporting symptoms characteristic of children with mild
persistent asthma or more severe asthma. Fifty percent and 54% of the children (completing
either Asthma Form 1 or Asthma Form 2) reported having asthma symptoms 3 days or more
in the past 2 weeks, with a range of 0 to 14 symptom days. Similarly, at least half of the
sample (50% completing Form 1, 54% completing Form 2) reported nocturnal asthma
symptoms 2 or more nights in the past 2 weeks. The majority of the children (55%
completing Asthma Form 1, 58% completing Asthma Form 2) reported using rescue
medication 2 times or more in the past 2 weeks, with a range of 0 to 42 times.
Table 2 provides the factor loadings and residual correlations from the CFA model. Prior
exploratory and confirmatory factor analytic models were necessary to develop a model that
is both substantively interpretable, and indicates close fit with the data. For this model, local
dependence, or nuisance multidimensionality, is indicated by a series of additional factors
(i.e., “Play,” “Attacks,” and “Scared”), where “Play,” for example, is represented by a
collection of items relating to difficulty playing due to asthma symptoms. In other cases,
pairs of items were locally dependent and were modeled with residual correlations (e.g., “I
went to the emergency room for my asthma” and “I went to the hospital for my asthma”
almost amount to asking the same question twice). Indices of goodness of fit, as suggested
by Reeve et al. (28), indicate that the model fits the data well, χ2(155) = 625, CFI
(Comparitive Fit Index) = 0.917, TLI (Tucker-Lewis Index) = 0.986, RMSEA (Root Mean
Square Error of Approximation) = 0.070.
To ensure that the final selection of items was unidimensional, a team of experts reviewing
CFA results selected one item to represent each locally dependent subset. In many instances
the selected item had the highest factor loading among the subset of items; in other instances
the selected item was substantively important to final scale (e.g., “I had asthma attacks” and
“It was hard for me to play sports or exercise because of my asthma”). The remaining items
were set aside, leaving 19 items that were calibrated using the GRM. Table 3 contains the
values of the item parameter estimates, item fit statistics (S-X2), and LR-DIF statistics for
the items comprising the final pool. In Table 3, the items are sorted based on the magnitude
of the slope parameter, so the generally best indicators of asthma impact are near the top.
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After using the Benjamini-Hochberg correction for multiplicity on both fit and DIF
statistics, no items exhibited significant lack of fit, and only one item, “My asthma was
really bad,” was set aside for significant DIF (χ2(5) = 18.3, p = .003). The item “I went to
the emergency room for my asthma” was removed due to its poor discrimination (a = 0.88).
The remaining 17 items in Table 3 comprise the asthma item pool.
Figure 1 provides test information functions for the asthma item pool and five potential short
forms on a T-score scale with a mean of 50 and standard deviation of 10 (on which all
PROMIS scales are reported). Test information, the expected value of the inverse of the
squared standard error of measurement, indicates the precision of scores on a scaled metric.
A standard error of measurement of approximately 0.32 (on a standardized metric, or 3.2 on
a T-score metric) is associated with a test information value of 10 and hence a reliability
coefficient of approximately 0.90. Figure 1 contains five potential 8-item short forms that
provide test information greater than 10 for a range of scores between, approximately, 30
and 70 on the T-score scale. The recommended 8-item short form in the Appendix is the
item set that provides the maximum test information at the mean (50) on the T-score metric.
However, if more score precision is required (or “broader” precision), the complete 17-item
pool is contained in Table 3 and may be used to compute IRT response pattern scores or
IRT-scaled scores for summed scores, or a computerized adaptive test (CAT) may be
administered using all 17 items as the pool. Conversely, if a researcher needs a shorter
assessment and can sacrifice precision, a shorter scale can be created and scores may be
generated on the T-score metric.
Figure 1 also serves as a simulated CAT, such that separate test information functions are
computed from the 8 items that provide the most information at five possible score locations
(30, 40, 50, 60, and 70 on the T-score metric). That is, the items used to generate the test
information function at each of the five score locations are those that perfect adaptation
would select for an individual at those score levels. To consider the usefulness of CAT given
these items, one may compare both the range of score precision and the magnitude of score
precision across the separate potential short forms. Because the items generally discriminate
in the same score range, there is little precision gained by choosing among the five potential
short forms. Additionally, relatively minor gains in reliability (approximately 0.03) were
noted when comparing test information functions for the full item pool compared to the
potential short forms. The PROMIS Assessment Center, available at www.nihpromis.org,
contains the item pool and is capable of administering these items as a CAT.
Discussion
We have described the development of the new NIH PROMIS Pediatric Asthma Impact
Scale (PAIS) using item response theory, including the investigations of scale
dimensionality, local dependence, and differential item functioning. After eliminating
asthma items exhibiting local dependence or differential item functioning, we present the
final 17–asthma item pool, as well as the recommended 8-item short form (Appendix 1).
Existing Asthma Quality of Life instruments/scales have covered a variety of asthma-related
domains: symptoms (daytime, nocturnal), emotion functioning/psychosocial health, physical
activities/functional limitations, worry/stigma, independence, environment, communication,
and treatment (9, 10, 13, 15, 17–20, 41–46). Our scale, based on the PROMIS asthma
domain definition, includes symptoms, as well as asthma-specific impact on functional
limitations, physical activities, emotional functioning, and psychosocial health.
Our Pediatric Asthma Impact Scale (PAIS) takes full advantage of IRT analyses in the scale
development process. As noted earlier, previous asthma quality of life scales used classical
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test theory. Several key assumptions in classical test theory do not always hold in practice.
These include (1) each item contributes equally to the final score, (2) all items have equal
variance, (3) each item is measured on the same interval scale, and (4) the error of
measurement is the same at the ends of the scale as it is in the middle (21). These
assumptions, however, are met in the PAIS items by virtue of being IRT based.
There is evidence that previously developed asthma quality of life scales discriminate less
well among people with more severe impairment in their quality of life as well as among
those with more mild limitations (22, 23). As Ahmed et al.’s analyses illustrate with IRT
analyses of the 30-Second Asthma Test, the items could only distinguish between high and
low levels of control, with no levels in between, whereas an ideal scale would have items
that assess distinct levels of asthma impact equally spaced apart on the IRT scale. The PAIS
items, developed with IRT, have this characteristic.
Furthermore, the PAIS provides assessment of asthma “impact” with high precision using a
relatively small set of items through the application of computerized adaptive testing (23).
As noted by Varni et al. (submitted) an additional potential advantage of utilizing IRT-
developed scales includes allowing greater flexibility for researchers in selecting items that
are the most meaningful for their study design and hypotheses.
Conclusions
The present study presents the PROMIS Pediatric Asthma Impact Scale (PAIS) developed
with IRT, and provides the initial calibration data for the items. Future work will include
testing of the scale’s reliability and validity, as well as responsiveness to clinical change.
References
1. Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health
Interview Survey, 2007. Vital Health Stat. 2009; 10(239):1–80.
2. Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J
Asthma. 2009; 46:73–80. [PubMed: 19191142]
3. Expert Panel Report 3 (EPR-3). Guidelines for the Diagnosis and Management of Asthma-Summary
Report 2007. J Allergy Clin Immunol. 2007; 120(5 Suppl):S94–S138. [PubMed: 17983880]
4. Castro M, Ramirez MI, Gern JE, Cutting G, Redding G, Hagood JS, et al. Strategic plan for
pediatric respiratory diseases research: an NHLBI working group report. Proc Am Thorac Soc.
2009; 6:1–10. [PubMed: 19131525]
5. Mangione-Smith R, Schonlau M, Chan KS, Keesey J, Rosen M, Louis TA, et al. Measuring the
effectiveness of a collaborative for quality improvement in pediatric asthma care: does
implementing the chronic care model improve processes and outcomes of care? Ambul Pediatr.
2005; 5:75–82. [PubMed: 15780018]
6. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in
the parents of children with asthma. Qual Life Res. 1996; 5:27–34. [PubMed: 8901364]
7. Creer TL, Wigal JK, Kotses H, McConnaughy K, Winder JA. A life activities questionnaire for
adult asthma. J Asthma. 1992; 29:393–399. [PubMed: 1429393]
8. Hyland ME, Finnis S, Irvine SH. A scale for assessing quality of life in adult asthma sufferers. J
Psychosom Res. 1991; 35:99–110. [PubMed: 2023146]
9. Varni JW, Burwinkle TM, Rapoff MA, Kamps JL, Olson N. The PedsQL in pediatric asthma:
reliability and validity of the Pediatric Quality of Life Inventory generic core scales and asthma
module. J Behav Med. 2004; 27:297–318. [PubMed: 15259457]
10. Chan KS, Mangione-Smith R, Burwinkle TM, Rosen M, Varni JW. The PedsQL: reliability and
validity of the short-form generic core scales and asthma module. Med Care. 2005; 43:256–265.
[PubMed: 15725982]
Yeatts et al. Page 7













11. Santanello NC. Pediatric asthma assessment: validation of 2 symptom diaries. J Allergy Clin
Immunol. 2001; 107(5 Suppl):S465–S472. [PubMed: 11344376]
12. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement
characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J. 1997;
10:646–651. [PubMed: 9072999]
13. Santanello NC, Demuro-Mercon C, Davies G, Ostrom N, Noonan M, Rooklin A, et al. Validation
of a pediatric asthma caregiver diary. J Allergy Clin Immunol. 2000; 106:861–866. [PubMed:
11080707]
14. Baars RM, Atherton CI, Koopman HM, Bullinger M, Power M. The European DISABKIDS
project: development of seven condition-specific modules to measure health related quality of life
in children and adolescents. Health Qual Life Outcomes. 2005; 3:70. [PubMed: 16283947]
15. Simeoni MC, Schmidt S, Muehlan H, Debensason D, Bullinger M. Field testing of a European
quality of life instrument for children and adolescents with chronic conditions: the 37-item
DISABKIDS Chronic Generic Module. Qual Life Res. 2007; 16:881–893. [PubMed: 17404899]
16. Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with
asthma. J Clin Epidemiol. 1992; 45:461–472. [PubMed: 1588352]
17. Vollmer WM, Markson LE, O’Connor E, Sanocki LL, Fitterman L, Berger M, et al. Association of
asthma control with health care utilization and quality of life. Am J Respir Crit Care Med. 1999;
160(5 Pt 1):1647–1652. [PubMed: 10556135]
18. Bukstein DA, McGrath MM, Buchner DA, Landgraf J, Goss TF. Evaluation of a short form for
measuring health-related quality of life among pediatric asthma patients. J Allergy Clin Immunol.
2000; 105(2 Pt 1):245–251. [PubMed: 10669843]
19. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, et al. Development and cross-
sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007;
119:817–825. [PubMed: 17353040]
20. Murphy KR, Zeiger RS, Kosinski M, Chipps B, Mellon M, Schatz M, et al. Test for respiratory and
asthma control in kids (TRACK): a caregiver-completed questionnaire for preschool-aged
children. J Allergy Clin Immunol. 2009; 123:833–839. e9. [PubMed: 19348922]
21. Streiner, D.; Norman, D. Health Measurement Scales: A Practical Guide to Their Development and
Use. 3. New York: Oxford University Press; 2003.
22. Adams R, Rosier M, Campbell D, Ruffin R. Assessment of an asthma quality of life scale using
item-response theory. Respirology. 2005; 10:587–593. [PubMed: 16268911]
23. Ahmed S, Ernst P, Tamblyn R, Colman N. Evaluating asthma control: a comparison of measures
using an item response theory approach. J Asthma. 2007; 44:547–554. [PubMed: 17885858]
24. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The Patient-Reported
Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap
cooperative group during its first two years. Med Care. 2007; 45(5 Suppl 1):S3–S11. [PubMed:
17443116]
25. DeWalt DA, Rothrock N, Yount S, Stone AA. Evaluation of item candidates: the PROMIS
qualitative item review. Med Care. 2007; 45(5 Suppl 1):S12–S21. [PubMed: 17443114]
26. Irwin DE, Varni JW, Yeatts K, DeWalt DA. Cognitive interviewing methodology in the
development of a pediatric item bank: a patient reported outcomes measurement information
system (PROMIS) study. Health Qual Life Outcomes. 2009; 7:3. [PubMed: 19166601]
27. Walsh TR, Irwin DE, Meier A, Varni JW, DeWalt DA. The use of focus groups in the
development of the PROMIS pediatrics item bank. Qual Life Res. 2008; 17:725–735. [PubMed:
18427951]
28. Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA, et al. Psychometric evaluation
and calibration of health-related quality of life item banks: plans for the Patient-Reported
Outcomes Measurement Information System (PROMIS). Med Care. 2007; 45(5 Suppl 1):S22–
S31. [PubMed: 17443115]
29. Hill CD, Edwards MC, Thissen D, Langer MM, Wirth RJ, Burwinkle TM, et al. Practical issues in
the application of item response theory—a demonstration using items from the pediatric quality of
life inventory (PedsQL) 4.0 generic core scales. Med Care. 2007; 45:S39–S47. [PubMed:
17443118]
Yeatts et al. Page 8













30. Muthen, L.; Muthen, BM. plus Users Guide. 2. Los Angeles: Muthen & Muthen; 2004.
31. Samejima F. Estimation of latent ability using a response pattern of graded scores. Psychometrika.
1969; 34(4 Pt 2):1–100.
32. Samejima, F. Graded response model. In: van der Linden, W.; Hambleton, RK., editors. Handbook
of Modern Item Response Theory. New York, NY: Springer-Verlag; 1997. p. 85-100.
33. du Toit, M. IRT from SSI. Lincolnwood, IL: Scientific Software International; 2003.
34. Orlando M, Thissen D. Further investigation of the performance of S-X2: an item fit index for use
with dichotomous item response theory models. Appl Psychol Meas. 2003; 27:289–298.
35. Bjorner, J.; Smith, J.; Edelen, M.; Stone, C.; Thissen, D.; Sun, X. IRTFIT: A Macro for Item Fit
and Local Dependence Tests Under IRT Models. Lincoln, RI: QualityMetric Incorporated; 2007.
36. Thissen, D.; Steinberg, L.; Wainer, H. Detection of differential item functioning using the
parameters of item response models. In: Holland, P.; Wainer, H., editors. Differential Item
Functioning. Hillsdale, NJ: Lawerence Erlbaum Associates; 1993. p. 67-113.
37. Thissen, D. IRTLRDIF: Software for the Computation of the Statistics Involved in Item Response
Theory Likelihood-Ratio Tests for Differential Item Functioning. Chapel Hill, NC: University of
North Carolina at Chapel Hill; 2001.
38. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach
to multiple testing. J R Stat Soc B. 1995; 57:289–300.
39. Williams VSL, Jones LV, Tukey JW. Controlling error in multiple comparisons, with examples
from state-to-state differences in educational achievement. J Educ Behav Stat. 1999; 24:42–69.
40. Thissen, D.; Nelson, L.; Rosa, K.; McLeod, LD. Item response theory for items scored in more
than two categories. In: Thissen, D.; Wainer, H., editors. Test Scoring. Mahwah, NJ: Lawrence
Erlbaum Associates; 2001. p. 141-186.
41. Juniper EF, Norman GR, Cox FM, Roberts JN. Comparison of the standard gamble, rating scale,
AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J. 2001; 18:38–44. [PubMed:
11510803]
42. Juniper EF, Svensson K, Mork AC, Stahl E. Measuring health-related quality of life in adults
during an acute asthma exacerbation. Chest. 2004; 125:93–97. [PubMed: 14718426]
43. Juniper EF, Svensson K, O’Byrne PM, Barnes PJ, Bauer CA, Lofdahl CG, et al. Asthma quality of
life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J. 1999;
14:1038–1043. [PubMed: 10596687]
44. Juniper EF, Wisniewski ME, Cox FM, Emmett AH, Nielsen KE, O’Byrne PM. Relationship
between quality of life and clinical status in asthma: a factor analysis. Eur Respir J. 2004; 23:287–
291. [PubMed: 14979505]
45. Schatz M, Mosen D, Apter AJ, Zeiger RS, Vollmer WM, Stibolt TB, et al. Relationship of
validated psychometric tools to subsequent medical utilization for asthma. J Allergy Clin
Immunol. 2005; 115:564–570. [PubMed: 15753905]
46. Schatz M, Mosen DM, Kosinski M, Vollmer WM, Magid DJ, O’Connor E, et al. The relationship
between asthma-specific quality of life and asthma control. J Asthma. 2007; 44:391–395.
[PubMed: 17613636]
Appendix
Listed below are the item stems for the recommended 8-item short form for the PROMIS
Pediatric Asthma Impact Scale. All items use a 7-day recall period (the preface is “In the
past 7 days”), and a 5-point response scale with the options never (0), almost never (1),
sometimes (2), often (3) and almost always (4).
I had trouble breathing because of my asthma.
My asthma bothered me.
I felt wheezy because of my asthma.
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It was hard to take a deep breath because of my asthma.
It was hard for me to play sports or exercise because of my asthma.
I had trouble sleeping at night because of my asthma.
My chest felt tight because of my asthma.
I felt scared that I might have trouble breathing because of my asthma.
The summed score to scale score translation for this short form is in Table A1.
Table A1
Summed score to scale score translation table for the recommended short form.
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Summed score Scale score SD
31 73 4
32 76 5
Note. Scale scores are on a T-score scale; the values of SD are reported as conditional standard errors of measurement.
Summed scores are the sum of each item score (0–4) for all 8 items; the scale scores represent the corresponding IRT score
for each summed score.
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Test information for asthma symptom items.
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Table 1
Survey participant demographic information.*
Asthma Form 1 (n =
318) n (%)
Asthma Form 2 (n =
304) n (%)
Total sample (N = 4129)
n (%)
Child’s gender
 Male 174 (54.7) 171 (56.3) 2038 (49.3)
 Female 143 (45.0) 133 (43.7) 2090 (50.6)
 Missing 1 (0.3) 0 1 (0.1)
Child’s age (years)
 8–12 211 (66.4) 180 (59.2) 2286 (55.4)
 13–17 106 (33.3) 121 (39.8) 1843 (44.4)
 Missing 1 (0.4) 3 (1.0) 10 (0.2)
Child’s race
 White 161 (50.6) 127 (41.8) 2400 (58.1)
 Black or African-American 97 (30.5) 118 (38.8) 957 (23.2)
 American Indian/Alaska Native 6 (1.9) 8 (2.6) 47 (1.1)
 Asian 0 2 (0.7) 48 (1.2)
 Native Hawaiian/Pacific Islander 1 (0.3) 1 (0.3) 9 (0.2)
 Other 18 (5.7) 23 (7.6) 302 (7.3)
 Multiple Races 26 (8.1) 22 (7.2) 242 (5.9)
 Missing 9 (2.8) 3 (1.0) 124 (3.0)
Child’s ethnicity
 Non Hispanic 269 (84.6) 255 (83.8) 3387 (82.1)
 Hispanic 46 (14.5) 44 (14.5) 703 (17.0)
 Missing 3 (0.9) 5 (1.7) 39 (0.9)
Child’s chronic conditions—6 months
 No 151 (47.5) 145 (47.7) 2951 (71.5)
 Yes 167 (52.5) 153 (50.3) 1156 (28.0)
 Missing 0 6 (2.0) 22 (0.5)
Guardian’s** relationship to child
 Parent 289 (90.9) 284 (93.4) 3822 (92.6)
 Grandparent 17 (5.3) 10 (3.3) 184 (4.5)
 Guardian or Other 12 (3.8) 10 (3.3) 119 (2.9)
 Missing 0 0 4 (0.1)
Guardian’s* education level
 ≤8th grade 7 (2.2) 3 (1.0) 74 (1.8)
 Some high school 25 (7.9) 16 (5.2) 243 (5.9)
 High school degree/GED 77 (24.2) 75 (24.7) 886 (21.5)
 Some college/technical degree 119 (37.4) 110 (36.2) 1405 (34.0)
 College degree 63 (19.8) 71 (23.4) 1001 (24.2)
 Advanced degree 27 (8.5) 28 (9.2) 510 (12.4)
 Missing 0 1 (0.3) 10 (0.2)
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Asthma Form 1 (n =
318) n (%)
Asthma Form 2 (n =
304) n (%)
Total sample (N = 4129)
n (%)
Data collection site
 Schools—NC 239 (5.8)
 Clinics—NC 223 (70.1) 215 (70.7) 2052 (49.7)
 Clinics—TX 95 (29.9) 89 (29.3) 1838 (44.5)
Asthma severity % (range) % (range)
 Daytime symptoms 3 or more times a week 50 (0–14) 54 (0–14) NA
 Night time symptoms 2 times or more in the past 2
weeks
50 (0–14) 53 (0–14) NA
 Rescue medication use 2 or more times in the past 2
weeks
56 (0–42) 58 (0–42)
*
These data are presented in Irwin et al. 2009 (submitted).
**
Guardian, parent, or caregiver completing sociodemographic form and signing consent documents.
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